The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clopidogrel     Quarter: 2016Q3

Total Drug/Injury Combinations: 736     Number of Pages: 37

DRUGNAME PT EventCount
CLOPIDOGREL Drug interaction 38 view events
CLOPIDOGREL Gastrointestinal haemorrhage 36 view events
CLOPIDOGREL Neutropenia 22 view events
CLOPIDOGREL Labelled drug-drug interaction medication error 20 view events
CLOPIDOGREL Contusion 18 view events
CLOPIDOGREL Haemorrhage intracranial 18 view events
CLOPIDOGREL Diarrhoea 17 view events
CLOPIDOGREL Epistaxis 17 view events
CLOPIDOGREL Loss of consciousness 17 view events
CLOPIDOGREL Haemoglobin decreased 16 view events
CLOPIDOGREL Febrile neutropenia 15 view events
CLOPIDOGREL Off label use 15 view events
CLOPIDOGREL BISULFATE. Gastrointestinal haemorrhage 15 view events
CLOPIDOGREL Chest pain 14 view events
CLOPIDOGREL Melaena 14 view events
CLOPIDOGREL Transient ischaemic attack 14 view events
CLOPIDOGREL Condition aggravated 13 view events
CLOPIDOGREL Dizziness 13 view events
CLOPIDOGREL Endothelial dysfunction 13 view events
CLOPIDOGREL Haematemesis 13 view events

Total Drug/Injury Combinations: 736     Number of Pages: 37

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)